Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Advanced Solid Tumors
Related studies linked through entity extraction aliases.
Safety and Efficacy of Metabolically Armed Tumor-Infiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
A Study of BGM-2121 in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Phase 1/2 Study of GW5282 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase I/II Study to Evaluate XNW34017 in Patients With Advanced or Metastatic Solid Tumor
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Study Evaluating the Efficacy and Safety of ABP1011T Tablets in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ZX-8177 in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
AT1019 Plus SBRT and PD-1 Inhibitor for Advanced Solid Tumors: An IIT Study
- Status
- RECRUITING
- Phase
- PHASE1
Personalized KXV01 Lentinvivo (TCR) Injection as the Therapy for Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
BTM-3566 in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Immune Cell Therapy for Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Phase I/II Clinical Study of WJ22096 Tablets in Patients With Advanced Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
GenSci143 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of GenSci140 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Sirolimus (Albumin-Bound) in Combination With Different ADCs Treatment of Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Test a New Immunotherapy, ABX-001, Alone and in Combination With the Marketed Drug, Pembrolizumab, for the Treatment of Tumors Previously Treated With Other Therapies
- Status
- RECRUITING
- Phase
- PHASE1